GDF15 and metabolic dysfunction-associated steatotic liver disease: Second, our findings suggest that circulating GDF-15 levels and specific DC subsets (e.g., CD123+ pDCs) may serve as valuable biomarkers for early identification of individuals at high risk for NAFLD progression, enabling timely preventive strategies.